Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 32)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A INFI: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
21-Nov-09 Reuters Investment Profile N/A Ismailia National Food Industries Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Standard & Poor's Quantitative Report N/A Infinity Pharmaceuticals 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: INFINITY PHARMA -- INFI 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ADLR , BIOD , INFI , JAV , KERX , MBRK , NGSX , SNTA -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of INFINITY PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: INFINITY PHARMACEUTICALS INC 5 $25 View Abstract
10-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 30 $75 View Abstract
Next 20

Brokerage Reports (Showing 1 to 5 of 5)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
10-Nov-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 30 $75 View Abstract
10-Nov-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino INFI Beats Consensus Q309 EPS 6 $25 View Abstract
10-Nov-09 Thomson StreetEvents N/A INFI - Event Transcript of Infinity Pharmaceuticals, Inc. conference call, Nov. 09, 2009 / 4:30pm ET 8 $75 View Abstract
26-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 17 $50 View Abstract
26-Oct-09 Roth Capital Partners, Inc. Scott R. Henry CFA, Andrew Vaino Q3 Earnings Preview 28 $75 View Abstract

Independent Reports (Showing 1 to 10 of 27)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A INFI: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
21-Nov-09 Reuters Investment Profile N/A Ismailia National Food Industries Co: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
21-Nov-09 Standard & Poor's Quantitative Report N/A Infinity Pharmaceuticals 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: INFINITY PHARMA -- INFI 1 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ADLR , BIOD , INFI , JAV , KERX , MBRK , NGSX , SNTA -- DRUGS 3 $4 View Abstract
20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of INFINITY PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: INFINITY PHARMACEUTICALS INC 5 $25 View Abstract
9-Nov-09 Zacks Investment Research Inc. N/A INFINITY PHARMA (INFI) Zacks Company Snapshot 1 $10 View Abstract
Next 17

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.